retatrutide release date Commercial Availability Timeline: Key Milestones and Costs Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

Ensures optimal absorption, enhanced stability, and superior results

The medication works on its own, but pairing it with simple home habits boosts monthly results and reduces side effects

Registered dietitian Ayla Barmmer told The New York Post that 15% of her GLP-1 patients have encountered fertility challenges, with 40% of that group experiencing irregular menstrual cycles, delayed ovulation, or declining sperm quality, outcomes likely tied to nutrient deficiencies resulting from rapid weight loss

However, given the novelty of this therapeutic approach, the available evidence may be influenced by publication bias and early optimism, and long-term mechanistic and clinical outcome data remain limited